Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

DGAP-Adhoc: CompuGroup Medical acquires EPSILOG


DGAP-Ad-hoc: CompuGroup Medical SE / Key word(s): Takeover
CompuGroup Medical acquires EPSILOG

27-Dec-2019 / 12:43 CET/CEST
Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.


27 December 2019 - Koblenz, Germany, & Castries, France.

Today, CompuGroup Medical SE, as purchaser, and Hevanance S.à r.l. and Goodwill Systems S.à r.l., as sellers, have signed an agreement regarding the sale and purchase of 100 % of the shares in MB Invest SAS which is the sole owner of EPSILOG SAS (EPSILOG), based in Castries, France.

EPSILOG's key product is VEGA, an ambulatory information system with a leading position in French healthcare IT for nurses and physiotherapists.

The agreed purchase price for EPSILOG amounts to EUR 72m and is subject to further adjustments post-closing. In 2018, EPSILOG had revenues of more than EUR 14 million with an EBITDA of approximately EUR 5 million. EPSILOG's customer base today consists of more than 44,000 providers across the ambulatory market segment.

Closing of the transaction is expected for 27 December 2019.

For further information please refer to:

CompuGroup Medical SE
Investor Relations
Maria Trost 21
56070 Koblenz, Germany

Contact person:
Claudia Thomé

Head of Investor Relations
CompuGroup Medical SE
Email: [email protected]
Tel +49 261 8000 7030
Tel +49 261 8000 6200


27-Dec-2019 CET/CEST The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de


Language: English
Company: CompuGroup Medical SE
Maria Trost 21
56070 Koblenz
Germany
Phone: +49 (0)261 8000 6200
Fax: +49 (0)261 8000 3200
E-mail: [email protected]
Internet: www.cgm.com
ISIN: DE0005437305
WKN: 543730
Indices: MDAX, TecDAX
Listed: Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Munich, Stuttgart, Tradegate Exchange
EQS News ID: 943855

 
End of Announcement DGAP News Service

943855  27-Dec-2019 CET/CEST

fncls.ssp?fn=show_t_gif&application_id=943855&application_name=news&site_id=sharewise

CompuGroup Medical SE Stock

€68.25
-0.730%
CompuGroup Medical SE shows a slight decrease today, losing -€0.200 (-0.730%) compared to yesterday.
The community is currently still undecided about CompuGroup Medical SE with 1 Buy predictions and 0 Sell predictions.
With a target price of 74 € there is a slightly positive potential of 8.42% for CompuGroup Medical SE compared to the current price of 68.25 €.
Like: 0
Share
EQS Group is a leading international provider of regulatory technology in the fields of corporate compliance and investor relations. In working with EQS Group, thousands of companies worldwide inspire trust by fulfilling complex national and international disclosure obligations, minimizing risks and communicating transparently with stakeholders.




Legal notice

Comments